Loading clinical trials...

Neural Components Underlying the Treatment of Adolescent Depression | Clinical Trials | Clareo Health

COMPLETEDNANCT01717508

Neural Components Underlying the Treatment of Adolescent Depression

The goal of the study is to examine how cognitive behavioral therapy (CBT), a common treatment for adolescent depression, affects brain functioning. Depressed adolescents will complete an initial asse...

Lead sponsor: Mclean Hospital•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 2

Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive Disorder

NCT07523048 · Major Depressive Disorder (MDD)

RECRUITINGPhase 2

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

NCT07226661 · Major Depressive Disorder (MDD)

RECRUITINGPhase 2

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

NCT07115329 · Major Depressive Disorder

RECRUITINGPhase 3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397 · Major Depressive Disorder (MDD), Depression in Adults, and more

RECRUITINGNA

Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk

NCT07025720 · Major Depressive Disorder (MDD), Suicidal Ideation

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 24, 2020Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment112

Start dateOct 2012

Last updatedFeb 24, 2020

Condition

Major Depressive Disorder

Locations shown

McLean Hospital

Belmont, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 24, 2020Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Neural Components Underlying the Treatment of Adolescent Depression

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive Disorder

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk

Trial snapshot

Condition

Locations shown

For caregivers